Brief: Deep Track Capital Reports Passive Stake Of 9.89% In Context Therapeutics As Of May 2, 2024
10/05/2024 21:34
May 10 (Reuters) -
Deep Track Capital:
* DEEP TRACK CAPITAL, LP REPORTS PASSIVE STAKE OF 9.89% IN
CONTEXT
THERAPEUTICS AS OF MAY 2, 2024- SEC FILING
Source text for Eikon: ID:n0001172661-24-002164
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202